Rapivab
Product Images NDC 61364-181

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rapivab (NDC 61364-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seqirus Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rap07 0001 01

Chemical structure diagram of Rapivab (peramivir) showing the molecular arrangement with multiple hydroxyl groups, amine groups, and carboxyl groups, including the three molecules of water of crystallization (3 H2O).*

FDA Label Image

Rap07 0001 02

Packaging label for Rapivab peramivir injection by Seqirus USA Inc. The label indicates a strength of 200 mg/20 mL per vial (10 mg/mL) and specifies use for intravenous infusion only, with instructions to dilute before use. The carton contains 3 vials and includes storage information and dosage details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.